Crofab 1GM 2S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9UC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,188
Award facts
- Contract value 100% obligated
- $16,188.41 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $16,188.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, with completion expected by the same date. This non-set-aside contract, designated as delivery order 4570464644 under CROFAB 1GM 2S, represents a task order executed against AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medical products including prescription medications, generic drugs, vaccines, and specialized medical devices to support military healthcare programs and veteran services.
This delivery order is one of numerous task orders issued under Cencora's overarching IDC with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The parent IDC serves as a global pharmaceutical support vehicle enabling the delivery of critical medical commodities across multiple therapeutic domains to military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The competitively awarded contract reflects AmerisourceBergen's established capability to efficiently fulfill federal pharmaceutical procurement requirements through open competition and demonstrated performance in the government medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FW9UC?
SPE2DR26FW9UC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FW9UC worth?
The government has obligated $16,188 on SPE2DR26FW9UC.
Is contract SPE2DR26FW9UC an order under another contract?
Yes. SPE2DR26FW9UC is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9UC competed?
The extent of competition for SPE2DR26FW9UC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award